Prevention and treatment of virulent bacterial biofilms with an enzymatic nitric oxide-releasing dressing

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 12, 2012, Pages 6095-6103

  Sulemankhil, Imran ^a   Ganopolsky, Jorge Gabriel ^b   Dieni, Christopher Anthony ^b   Dan, Andrei Florin ^a   Jones, Mitchell Lawrence ^a,b   Prakash, Satya ^a  

^a MCGILL UNIVERSITY   (Canada)

^b Micropharma Ltd   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE;

ACINETOBACTER BAUMANNII; ARTICLE; BACTERICIDAL ACTIVITY; BANDAGES AND DRESSINGS; BIOFILM; CELL DEATH; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

ACINETOBACTER BAUMANNII; ANTI-INFECTIVE AGENTS, LOCAL; BACTERIAL INFECTIONS; BANDAGES; BIOFILMS; COLONY COUNT, MICROBIAL; DOSE-RESPONSE RELATIONSHIP, DRUG; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, CONFOCAL; NITRIC OXIDE; PSEUDOMONAS AERUGINOSA;

EID: 84869236216     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01173-12     Document Type: Article

References (51)

1. Anstead GM, Quinones-Nazario G, Lewis JS, II. 2007. Treatment of infections caused by resistant Staphylococcus aureus. Methods Mol. Biol. 391:227-258.
2. Bae YJ, et al. 2008. A case of anaphylaxis to chlorhexidine during digital rectal examination. J. Korean Med. Sci. 23:526-528.
3. Balin AK, Pratt L. 2002. Dilute povidone-iodine solutions inhibit human skin fibroblast growth. Dermatol. Surg. 28:210-214.
4. Barraud N, et al. 2006. Involvement of nitric oxide in biofilm dispersal of Pseudomonas aeruginosa. J. Bacteriol. 188:7344-7353.
5. Barraud N, et al. 2009. Nitric oxide-mediated dispersal in single- and multi-species biofilms of clinically and industrially relevant microorganisms. Microb. Biotechnol. 2:370-378.
6. Bester E, Kroukamp O, Wolfaardt GM, Boonzaaier L, Liss SN. 2010. Metabolic differentiation in biofilms as indicated by carbon dioxide production rates. Appl. Environ. Microbiol. 76:1189-1197.
7. Bouza E, Burillo A, Munoz P. 2002. Catheter-related infections: diagNOsis and intravascular treatment. Clin. Microbiol. Infect. 8:265-274.
8. Brooun A, Liu S, Lewis K. 2000. A dose-response study of antibiotic resistance in Pseudomonas aeruginosa biofilms. Antimicrob. Agents Chemother. 44:640-646.
9. Cals-Grierson MM, Ormerod AD. 2004. Nitric oxide function in the skin. Nitric oxide 10:179-193.
10. Carpenter AW, Schoenfisch MH. 2012. Nitric oxide release: part II. Therapeutic applications. Chem. Soc. Rev. 41:3742-3752.
11. Costerton JW. 1984. The etiology and persistence of cryptic bacterial infections: a hypothesis. Rev. Infect. Dis. 6(Suppl. 3):S608-S616.
12. DeQueiroz GA, Day DF. 2007. Antimicrobial activity and effectiveness of a combination of sodium hypochlorite and hydrogen peroxide in killing and removing Pseudomonas aeruginosa biofilms from surfaces. J. Appl. Microbiol. 103:794-802.
13. Edwards R, Harding KG. 2004. Bacteria and wound healing. Curr. Opin. Infect. Dis. 17:91-96.
14. Engelsman AF, et al. 2009. Antimicrobial effects of an NO-releasing poly(ethylene vinylacetate) coating on soft-tissue implants in vitro and in a murine model. Acta Biomaterialia 5:1905-1910.
15. Fang FC. 1997. Perspectives series: host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity. J. Clin. Invest. 99:2818-2825.
16. Francolini I, Donelli G, Stoodley P. 2003. Polymer designs to control biofilm growth on medical devices. Rev. Environ. Sci. Biotechnol. 2:307-319.
17. Fukuto JM, Cho JY, Switzer CH. 2000. The chemical properties of nitric oxide and related nitrogen oxides, p 23-40. In Ignarro LJ (ed), Nitric oxide: biology and pathology. Academic Press, San Diego, CA.
18. Ghaffari A, Miller CC, McMullin B, Ghahary A. 2006. Potential application of gaseous nitric oxide as a topical antimicrobial agent. Nitric Oxide 14:21-29.
19. Gorwitz RJ. 2008. A review of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections. Pediatr. Infect. Dis. J. 27:1-7.
20. 15N]nitrate in biological fluids. Anal. Biochem. 126:131-138.
21. Hall-Stoodley L, Costerton JW, Stoodley P. 2004. Bacterial biofilms: from the natural environment to infectious diseases. Nat. Rev. Microbiol. 2:95-108.
22. Hall-Stoodley L, Stoodley P. 2009. Evolving concepts in biofilm infections. Cell Microbiol. 11:1034-1043.
23. Hetrick EM, Schoenfisch MH. 2006. Reducing implant-related infections: active release strategies. Chem. Soc. Rev. 35:780-789.
24. Hetrick EM, Shin JH, Paul HS, Schoenfisch MH. 2009. Anti-biofilm efficacy of nitric oxide-releasing silica nanoparticles. Biomaterials 30:2782-2789.
25. Hetrick EM, et al. 2008. Bactericidal efficacy of nitric oxide-releasing silica nanoparticles. ACS Nano 2:235-246.
26. Jardeleza C, et al. 2011. The effects of nitric oxide on Staphylococcus aureus biofilm growth and its implications in chronic rhinosinusitis. Int. Forum Allergy Rhinol. 1:438-444.
27. Jones M, et al. 2012. Novel nitric oxide producing probiotic wound healing patch: preparation and in vivo analysis in a New Zealand white rabbit model of ischaemic and infected wounds. Int. Wound J. 9:330-343.
28. Jones ML, Ganopolsky JG, Labbe A, Prakash S. 2010. A novel nitric oxide producing probiotic patch and its antimicrobial efficacy: preparation and in vitro analysis. Appl. Microbiol. Biotechnol. 87:509-516.
29. Juedes MJ, Wogan GN. 1996. Peroxynitrite-induced mutation spectra of pSP189 following replication in bacteria and in human cells. Mutation Res. 349:51-61.
30. Lancaster JR. 1997. A tutorial on the diffusibility and reactivity of free nitric oxide. Nitric Oxide 1:18-30.
31. Major TA, et al. 2010. Sodium nitrite-mediated killing of the major cystic fibrosis pathogens Pseudomonas aeruginosa, Staphylococcus aureus, and Burkholderia cepacia under anaerobic planktonic and biofilm conditions. Antimicrob. Agents Chemother. 54:4671-4677.
32. Meyer B. 2003. Approaches to prevention, removal and killing of biofilms. Int. Biodeterior. Biodegradation 51:249-253.
33. Miller CC, Miller MK, Ghaffari A, Kunimoto B. 2004. Treatment of chronic nonhealing leg ulceration with gaseous nitric oxide: a case study. J. Cutan. Med. Surg. 8:233-238.
34. Moller MN, Li Q, Lancaster JR, Jr, Denicola A. 2007. Acceleration of nitric oxide autoxidation and nitrosation by membranes. IUBMB Life 59:243-248.
35. Nordmann P, Naas T, Fortineau N, Poirel L. 2007. Superbugs in the coming new decade; multidrug resistance and prospects for treatment of Staphylococcus aureus, Enterococcus spp. and Pseudomonas aeruginosa in 2010. Curr. Opin. Microbiol. 10:436-440.
36. O'Grady N, et al. 2002. Guidelines for the prevention of intravascular catheter-related infections. Am. J. Infect. Control 30:476-489.
37. O'Toole G, Kaplan HB, Kolter R. 2000. Biofilm formation as microbial development. Annu. Rev. Microbiol. 54:49-79.
38. Park SY, et al. 1999. Potentiation of hydrogen peroxide, nitric oxide, and cytokine production in RAW 264.7 macrophage cells exposed to human and commercial isolates of Bifidobacterium. Int. J. Food Microbiol. 46:231-241.
39. Phillips PL, Yang Q, Sampson E, Schultz G. 2010. Effects of antimicrobial agents on an in vitro biofilm model of skin wounds, p 299-304. In Sen CK (ed), Advances in wound care, vol 1. Mary Ann Liebert, New Rochell, NY.
40. Privett BJ, Nutz ST, Schoenfisch MH. 2010. Efficacy of surface-generated nitric oxide against Candida albicans adhesion and biofilm formation. Biofouling 26:973-983.
41. Raulli R, McElhaney-Feser G, Hrabie JA, Cihlar RL. 2002. Antimicrobial properties of nitric oxide using diazeniumdiolates as the nitric oxide donor. Recent Res. Dev. Microbiol. 6:177-183.
42. Regev-Shoshani G, Ko M, Miller C, Av-Gay Y. 2010. Slow release of nitric oxide from charged catheters and its effect on biofilm formation by Escherichia coli. Antimicrob. Agents Chemother. 54:273-279.
43. Sandal I, Hong W, Swords WE, Inzana TJ. 2007. Characterization and comparison of biofilm development by pathogenic and commensal isolates of Histophilus somni. J. Bacteriol. 189:8179-8185.
44. Stamler JS. 1995. S-nitrosothiols and the bioregulatory actions of nitrogen oxides through reactions with thiol groups. Curr. Top. Microbiol. Immunol. 196:19-36.
45. Stewart PS, Costerton JW. 2001. Antibiotic resistance of bacteria in biofilms. Lancet 358:135-138.
46. Stickler D, Hewett P. 1991. Activity of antiseptics against biofilms of mixed bacterial species growing on silicone surfaces. Eur. J. Clin. Microbiol. Infect. Dis. 10:416-421.
47. Sutherland I. 2001. Biofilm exopolysaccharides: a strong and sticky framework. Microbiology 147:3-9.
48. Thompson R, Elliott V, Mondry A. 2009. Argyria: permanent skin discoloration following protracted colloid silver ingestion. BMJ Case Rep. 2009:bcr08.2008.0606. doi:10.1136/bcr.08.2008.0606.
49. Vazquez-Torres A, Jones-Carson J, Balish E. 1996. Peroxynitrite contributes to the candidacidal activity of nitric oxide-producing macrophages. Infect. Immun. 64:3127-3133.
50. Weigel LM, et al. 2007. High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm. Antimicrob. Agents Chemother. 51:231-238.
51. Zacharia IG, Deen WM. 2005. Diffusivity and solubility of nitric oxide in water and saline. Ann. Biomed. Eng. 33:214-222.